OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
Bertrand Allard, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101188-101188
Open Access | Times Cited: 14
Bertrand Allard, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101188-101188
Open Access | Times Cited: 14
Showing 14 citing articles:
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
The landscape of cancer-rewired GPCR signaling axes
Chakit Arora, Marin Matic, Luisa Bisceglia, et al.
Cell Genomics (2024) Vol. 4, Iss. 5, pp. 100557-100557
Open Access | Times Cited: 6
Chakit Arora, Marin Matic, Luisa Bisceglia, et al.
Cell Genomics (2024) Vol. 4, Iss. 5, pp. 100557-100557
Open Access | Times Cited: 6
The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial
Adil Khaliq, Haroon Badshah, Yasar Shah, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40356-e40356
Open Access | Times Cited: 5
Adil Khaliq, Haroon Badshah, Yasar Shah, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40356-e40356
Open Access | Times Cited: 5
Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation
Weize Zhu, Ying Hong, Zhaowei Tong, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101477-101477
Open Access | Times Cited: 4
Weize Zhu, Ying Hong, Zhaowei Tong, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101477-101477
Open Access | Times Cited: 4
A comprehensive analysis of deubiquitinase USP20 on prognosis and immunity in pan‐cancer
Ting Wang, Yibing Bai, Yi Dong, et al.
The FASEB Journal (2025) Vol. 39, Iss. 8
Closed Access
Ting Wang, Yibing Bai, Yi Dong, et al.
The FASEB Journal (2025) Vol. 39, Iss. 8
Closed Access
Caffeine: a potential mechanism for anti-obesity
Meng C. Wang, Wei Guo, Jiang‐Fan Chen
Purinergic Signalling (2024)
Closed Access | Times Cited: 2
Meng C. Wang, Wei Guo, Jiang‐Fan Chen
Purinergic Signalling (2024)
Closed Access | Times Cited: 2
Combined cancer immunotherapy based on targeting adenosine pathway and PD-1/PDL-1 axis
Mehrdad Fathi, Asieh Zarei, Ata Moghimi, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 9, pp. 757-777
Closed Access | Times Cited: 2
Mehrdad Fathi, Asieh Zarei, Ata Moghimi, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 9, pp. 757-777
Closed Access | Times Cited: 2
Angelicin: A leading culprit involved in fructus Psoraleae liver injury via inhibition of VKORC1
Xuan Tang, Jiayin Han, Pan Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 117917-117917
Closed Access | Times Cited: 1
Xuan Tang, Jiayin Han, Pan Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 117917-117917
Closed Access | Times Cited: 1
Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer
Aditya Shreenivas, Daisuke Nishizaki, Suzanna Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4742-4742
Open Access
Aditya Shreenivas, Daisuke Nishizaki, Suzanna Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4742-4742
Open Access
Overview of the role of purinergic signaling and insights into its role in cancer therapy
Francesco Di Virgilio, Valentina Vultaggio-Poma, Mario Tarantini, et al.
Pharmacology & Therapeutics (2024) Vol. 262, pp. 108700-108700
Open Access
Francesco Di Virgilio, Valentina Vultaggio-Poma, Mario Tarantini, et al.
Pharmacology & Therapeutics (2024) Vol. 262, pp. 108700-108700
Open Access
Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
Centura R. Anbarasu, Sophia Williams‐Perez, E. Ramsay Camp, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2773-2773
Open Access
Centura R. Anbarasu, Sophia Williams‐Perez, E. Ramsay Camp, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2773-2773
Open Access
The different effects of four adenosine receptors in liver fibrosis
Lan Yang, Zhaowei Gao, Xi Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Lan Yang, Zhaowei Gao, Xi Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
New MiniPromoter Ple389 (ADORA2A) drives selective expression in medium spiny neurons in mice and non-human primates
A. Gomes, Terri L. Petkau, Andrea J. Korecki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A. Gomes, Terri L. Petkau, Andrea J. Korecki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
